Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schauer, Franziska
NCT04971161 / 2020-004960-24: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)	Active, not recruiting	2	152	Europe	allo-APZ2-CVU, Skin-derived ABCB5-positive dermal mesenchymal stromal cells, Placebo	RHEACELL GmbH & Co. KG, FGK Clinical Research GmbH	Skin Ulcer Venous Stasis Chronic	06/26	06/26
Kiritsi, Dimitra
NCT04908215 / 2021-000214-42: INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa	Completed	2	19	Europe, RoW	INM-755 (cannabinol) cream, Vehicle Cream	InMed Pharmaceuticals Inc.	Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica, Kindler Syndrome	04/23	04/23
NCT04971161 / 2020-004960-24: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)	Active, not recruiting	2	152	Europe	allo-APZ2-CVU, Skin-derived ABCB5-positive dermal mesenchymal stromal cells, Placebo	RHEACELL GmbH & Co. KG, FGK Clinical Research GmbH	Skin Ulcer Venous Stasis Chronic	06/26	06/26
Zarzour, Abdou
NCT04971161 / 2020-004960-24: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)	Active, not recruiting	2	152	Europe	allo-APZ2-CVU, Skin-derived ABCB5-positive dermal mesenchymal stromal cells, Placebo	RHEACELL GmbH & Co. KG, FGK Clinical Research GmbH	Skin Ulcer Venous Stasis Chronic	06/26	06/26